HKND:NYE-Humankind Benefit Corporation - Humankind US Stock ETF (USD)

ETF | Others |

Last Closing

USD 30.3066

Change

0.00 (0.00)%

Market Cap

USD 0.13B

Volume

16.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE SOJE

-0.14 (-0.72%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

+0.07 (+0.12%)

USD 32.43B
DTB DTB

-0.14 (-0.72%)

USD 26.58B
DFAC Dimensional U.S. Core Equity 2..

+0.03 (+0.09%)

USD 26.00B
GBTC Grayscale Bitcoin Trust (BTC)

-1.58 (-2.84%)

USD 23.75B
JPST JPMorgan Ultra-Short Income ET..

-0.01 (-0.02%)

USD 22.73B
SGOV iShares® 0-3 Month Treasury B..

+0.03 (+0.03%)

USD 19.79B
AVUV Avantis® U.S. Small Cap Value..

-0.46 (-0.50%)

USD 10.49B
DFUV Dimensional US Marketwide Valu..

+0.08 (+0.20%)

USD 10.15B
DFAT Dimensional U.S. Targeted Valu..

-0.15 (-0.28%)

USD 9.40B

ETFs Containing HKND

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.58% 62% D 63% D
Dividend Return 0.34% 27% F 19% F
Total Return 3.93% 61% D- 60% D-
Trailing 12 Months  
Capital Gain 10.12% 56% F 61% D-
Dividend Return 0.81% 11% F 8% B-
Total Return 10.93% 53% F 55% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.88% 55% F 44% F
Dividend Return 1.75% 53% F 36% F
Total Return 0.87% 45% F 21% F
Risk Return Profile  
Volatility (Standard Deviation) 6.62% 67% D+ 89% A-
Risk Adjusted Return 26.45% 53% F 49% F
Market Capitalization 0.13B 68% D+ 28% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.